Gene Study Points Researchers to New Pathway for Leukemia
Leukemia is one of the hardest cancers to treat, but scientists have discovered a new, targetable pathway in one of the worst subtypes of the disease.
Labs Play Critical Role in Lymphoma Immunotherapy Trial
UR Medicine Central Labs and UR Medicine Labs have been providing essential, behind-the-scenes services for a cancer immunotherapy trial that recently received a lot of local publicity.